Screenshot 2022-04-21 at 19.20.56

Hosting Institution

European Paediatric Formulation Initiative in partnership with International Association for Pharmaceutical Technology.

EuPFI22 - Successful hybrid conference

The European Paediatric Formulation Initiative (EuPFI) successfully convened in-person annual conference for the first time since the pandemic, with the 14th annual conference, EuPFI2022, that took place from 20-22nd September in Rome, Italy. It was an event dedicated to formulating better medicines for children. It was aimed at creating a common platform for researchers, scientists, and students at the crossroads of drug development and paediatric considerations, to share ideas and innovations, and to facilitate fruitful discussions on recent innovations that will spur advancements in paediatric drug development. We are delighted that after successfully convening last 2 conferences virtually to keep professionals abreast of developments during the pandemic. Old participants were once again able to meet in person and make new friends. We are pleased to get back to what we do best by welcoming this important conference. It was a significant moment to be on the cusp of opening our doors to a major conference. One of the things we learned during the pandemic was that providing a virtual option really makes the conference accessible to people who would never be able to attend our programs in person. Hence, a hybrid conference with both online and in-person options was provided and was successful. EuPFI 2022 showcased the recent developments to improve the paediatric medicines landscape and and looks forward to seeing all again in Dublin next year #EuPFI2023 to make a positive difference towards addressing the unmet medical needs of children.

Conference venue

BMercure Roma West Hotel Via Eroi Di Cefalonia 301 00128 Rome


EuPFI 2022 Programme - Click here

Sign up to our mailing list here and we will send you an email when the programme is online and keep visiting the website for conference updates in the meanwhile.

Plenary Presentations

MiniMox -Treatment for all: Developing a paediatric formulation moxidectin for neglected infectious diseases
Hannah Batchelor, Strathclyde Institute of Pharmacy and Biomedical Sciences, United Kingdom

Formulation administration in global pediatric patients (virtual talk)
Mona D. Shah, Genentech, Inc., United States/p>

Focus Session Presentations

Taste Assessment and Taste Masking

Flavouring of Pharmaceuticals
Jerome Barra, Firmenich, Switzerland

Kimozo® Formulation and assessment of a novel and ready-to-use liquid formulation of temozolomide for children
Caroline Lemarchand, Orphelia pharma, France

Age appropriateness of formulations

Biomechanics and fluid mechanics of swallowing to develop in vitro swallowability testing method
Marco Ramajoli, U.Paris-Saclay, INRAE, France

Children can swallow tablets
Louise Bracken, Paediatric Medicines Research Unit, Alder Hey Children’s NHS Foundation Trust, United Kingdom

The Composite Endpoint: A new Methodology to Determine Acceptability of Oral Drug Formulations in the Pediatric Population
Viviane Klingmann, University Hospital Düsseldorf, Germany

Acceptability of Pediatric Formulations: Some considerations for patient and drug product interface focusing on swallowability
Arzu Selen, CDER/FDA, United States/ Steve Hoag, University of Maryland, United States

Administration Devices

Path into microneedles to tackle global healthcare challenges in paediatric population
Alejandro Paredes, Queen‘s University Belfast, United Kingdom

Designing a child-friendly, comic book style IFU to improve pediatric engagement in medication administration (virtual talk)
Joy Borgardt, AbbVie, United States


Insight into gastrointestinal fluids as a key factor for drug absorption in children
Joachim Brouwers, Catholic University of Leuven, Belgium

Physiologically-Based Pharmacokinetic paediatric skin model (virtual talk)
Andrea Edginton, University of Waterloo, Canada


The Titanium Dioxide (E171) ban in foods in Europe and the impact on Paediatric Drug Products in the EU
Kevin Hughes, IPEC, United Kingdom

Short talk Presentations

PADDINGToN: What do parents want to know about medicines?
Andrea Gill, Alder Hey Children‘s NHS Foundation Trust, United Kingdom

Taste masked artesunate/amodiaquine anti-malarial combination therapy: the role of partnerships in paediatric development
Fang Liu, University of Hertfordshire, United Kingdom; Sejal Ranmal, UCL School of Pharmacy, United Kingdom

Compatibility of parenteral nutrition solutions with intravenous medication in neonates, infants and children
Dr Fiona O’Brien, Prof Naomi McCallion, Dr Mahmound Farhan, Royal College of Surgeons in Ireland, Rotunda Hospital Dublin, Ireland

Forging new partnerships to advance paediatric formulations development: an overview of NIH resources spanning the formulation development lifecycle
James E. Cummins, Preclinical Microbicide and Prevention Reserach Branch PSP/DAIDS/NIAID/NIH, United States

Three Best Poster Award Winners:

  • Nicole Kaneria, School of Pharmacy, University College London: Small cellulose (nanocellulose) for small patients
  • Soniya Notani, School of Pharmacy, University College London: A pilot study to assess the user perspectives of using minitablets vs conventional tablets in children - views from a UK primary school
  • Lisa Freerks, Department of Pharmacy, University of Greifswald, Germany; A toolbox for simulating gastrointestinal conditions in children: Standardised dissolution media for simulating typical children's breakfasts around the world
  • Young Scientist Award Winner:

  • Jan Goelen, University of Birmingham, United Kingdom : Impact of colonic fluid volume on absorption of an XR quetiapine formulation in paediatrics: a PBPK study.
  • I am message box. Click edit button to change this text.

    Print Friendly, PDF & Email